These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 336801)

  • 21. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen.
    Kasper DL; Onderdonk AB; Reinap BG; Linberg AA
    J Infect Dis; 1980 Nov; 142(5):750-6. PubMed ID: 7462689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum antibody response to Bacteroides fragilis in women with abscesses following hysterectomy.
    Polk BF; Kasper DL; Shapiro M; Tager IB; Schoenbaum SC; Goldstein PR
    Obstet Gynecol; 1980 Feb; 55(2):163-6. PubMed ID: 7352073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and identification of encapsulated strains of Bacteroides fragilis.
    Kasper DL; Hayes ME; Reinap BG; Craft FO; Onderdonk AB; Polk BF
    J Infect Dis; 1977 Jul; 136(1):75-81. PubMed ID: 328787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum antibody response to Bacteroides fragilis in experimental sinusitis.
    Westrin KM; Stierna P; Weintraub A; Palmgren AC; Nord CE
    Infection; 1991; 19(6):435-9. PubMed ID: 1816114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune mechanisms in the prevention of intra-abdominal abscess formation.
    Kasper DL; Finberg RF; Crabb J; Onderdonk AB
    Scand J Infect Dis Suppl; 1989; 62():29-34. PubMed ID: 2587962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Bacteroides fragilis by indirect immunofluorescence.
    Weintraub A; Lindberg AA; Nord CE
    Med Microbiol Immunol; 1979; 167(4):223-30. PubMed ID: 94651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the common immunodominant antigenic determinant in the lipopolysaccharide of Bacteroides fragilis by a monoclonal antibody.
    Linko L; Weintraub A; Arstila P; Pelliniemi LJ; Viljanen MK
    Scand J Immunol; 1987 May; 25(5):469-75. PubMed ID: 2438749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.
    Zaleznik DF; Zhang ZL; Onderdonk AB; Kasper DL
    J Infect Dis; 1986 Jul; 154(1):40-6. PubMed ID: 3711690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.
    Kalka-Moll WM; Wang Y; Comstock LE; Gonzalez SE; Tzianabos AO; Kasper DL
    Infect Immun; 2001 Apr; 69(4):2339-44. PubMed ID: 11254591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal model system for studying virulence of and host response to Bacteroides fragilis.
    Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced bacterial dissemination and liver injury in CD14-deficient mice following a chronic abscess-forming peritonitis induced by Bacteroides fragilis.
    Woltmann A; Gangloff SC; Bruch HP; Rietschel ET; Solbach W; Silver J; Goyert SM
    Med Microbiol Immunol; 1999 Mar; 187(3):149-56. PubMed ID: 10206146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
    Kalka-Moll WM; Tzianabos AO; Wang Y; Carey VJ; Finberg RW; Onderdonk AB; Kasper DL
    J Immunol; 2000 Jan; 164(2):719-24. PubMed ID: 10623815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses.
    Zaleznik DF; Finberg RW; Shapiro ME; Onderdonk AB; Kasper DL
    J Clin Invest; 1985 Mar; 75(3):1023-7. PubMed ID: 2579976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.
    Tzianabos AO; Onderdonk AB; Zaleznik DF; Smith RS; Kasper DL
    Infect Immun; 1994 Nov; 62(11):4881-6. PubMed ID: 7927768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis.
    Gibson FC; Onderdonk AB; Kasper DL; Tzianabos AO
    J Immunol; 1998 May; 160(10):5000-6. PubMed ID: 9590249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental intraabdominal abscess formation by Escherichia coli and bacteroides fragilis.
    Hagen JC; Wood WS; Hashimoto T
    Eur J Clin Microbiol; 1983 Feb; 2(1):43-9. PubMed ID: 6341050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
    Wade BH; Kasper DL; Mandell GL
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing.
    Connolly JC; McLean C; Tabaqchali S
    J Med Microbiol; 1984 Jun; 17(3):259-71. PubMed ID: 6374150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
    Pantosti A; Colangeli R; Tzianabos AO; Kasper DL
    J Clin Microbiol; 1995 Oct; 33(10):2647-52. PubMed ID: 8567899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.